JNJ vs MRK
By Alex · Tickerpine
Johnson & Johnson vs Merck & Co., Inc., side by side — the numbers that matter, in plain English. No “winner” hype; you decide.
| Metric | JNJ | MRK |
|---|---|---|
| Price | $271.22 | $148.78 |
| Market cap | $653.61B | $367.07B |
| P/E ratio | 31.5 | 119.0 |
| ROE | 25.74% | 6.96% |
| Profit margin | 21.48% | 4.77% |
| Revenue growth | 6.60% | 5.10% |
| Dividend yield | 1.98% | 2.29% |
| Beta | 0.23 | 0.23 |
Green = the more favorable figure for that metric (lower P/E, higher ROE, margin, growth and yield). Not a recommendation.
JNJ vs MRK in plain English
- JNJ is the bigger company — about 1.8× the market cap of MRK.
- JNJ is cheaper on earnings (P/E 31.5 vs 119.0).
- JNJ earns a higher return on equity (26% vs 7%).
- JNJ is growing revenue faster (7% vs 5%).
- MRK has the higher dividend yield (2.29% vs 1.98%).
How would $1,000 have done in each?
JNJ return calculator
See what $1,000 in Johnson & Johnson would be worth today.
MRK return calculator
See what $1,000 in Merck & Co., Inc. would be worth today.
Figures from public market data, may be delayed. Comparison is informational only — not investment advice.